Does taking propranolol at bedtime cause insomnia, and does mirtazapine's alpha‑2 adrenergic antagonism lead to sleeplessness?

Propranolol and Insomnia: Understanding the Paradox

Propranolol, particularly when taken at bedtime, can indeed cause insomnia rather than promote sleep, and this effect is well-documented for lipophilic beta-blockers. 1, 2

Propranolol's Sleep-Disrupting Effects

Propranolol is a lipophilic (fat-soluble) beta-blocker that readily crosses the blood-brain barrier, leading to central nervous system effects that disrupt sleep architecture 3, 4. The evidence demonstrates:

• Increased nighttime awakenings: Lipophilic beta-blockers like propranolol significantly increase waking episodes during the night 2
• Reduced REM sleep: Propranolol decreases REM (rapid eye movement) sleep frequency 2, 4
• Paradoxical dream recall: Despite reducing actual REM sleep, the increased awakenings lead to more remembered dreams and nightmares 2
• Dose-dependent risk: Elderly patients on propranolol have the highest risk of insomnia compared to other beta-blockers, with selective beta-1 blockers showing 52% lower risk (adjusted OR 0.48) 1

A controlled trial specifically testing propranolol 80 mg for insomnia found it worsened insomnia rather than improving it, confirming it has no hypnotic properties 5.

Clinical Recommendation for Propranolol Timing

Avoid bedtime dosing of propranolol in patients with existing sleep complaints. If propranolol is necessary, consider:

• Switching to hydrophilic beta-blockers (atenolol, bisoprolol) which have 53-69% lower insomnia risk 1
• Administering propranolol earlier in the day
• Using selective beta-1 blockers with low lipophilicity when sleep is a concern 3, 1

---

Mirtazapine: Why an Alpha-2 Antagonist Promotes Sleep

Your question contains a pharmacological misconception: mirtazapine's alpha-2 antagonism actually promotes sleep rather than causing sleeplessness, and this is one of its primary therapeutic effects. 6, 7

The Mechanism Explained

Mirtazapine is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA) 8. Its alpha-2 adrenergic antagonism works differently than you might expect:

• Presynaptic alpha-2 blockade: This increases norepinephrine release, which provides antidepressant effects
• Postsynaptic effects: Mirtazapine also blocks histamine H1 receptors (strong antihistamine effect) and specific serotonin receptors (5-HT2, 5-HT3)
• Net sedating effect: The antihistamine properties dominate, producing marked sedation 7

Clinical Evidence for Mirtazapine as a Sleep Aid

Mirtazapine is specifically recommended as a sedating antidepressant for treating insomnia in multiple clinical guidelines:

• Listed as a treatment option for refractory insomnia, particularly effective in patients with comorbid depression and anorexia 6
• Recommended in the treatment sequence for chronic insomnia when benzodiazepine receptor agonists fail 9
• Somnolence is the most common side effect, occurring in 54% of patients (vs 18% placebo) 7
• FDA labeling explicitly warns about sleepiness and impaired ability to operate machinery 7

Dose-Related Effects

The "activating at higher doses" theory is not supported by evidence. A 2019 study analyzing 308 adverse events found no statistically significant increase in activating side effects (anxiety, agitation, insomnia, tachycardia) at higher mirtazapine doses after controlling for prescribing frequency 10. This contradicts the common clinical belief.

Practical Prescribing

Mirtazapine should be taken once daily, preferably at bedtime 7:

• Typical starting dose: 15 mg at bedtime
• The sedating effect is consistent across the therapeutic dose range (15-45 mg)
• Patients should be warned about next-day sedation and avoid driving until they know how it affects them 7

---

Key Clinical Pitfalls to Avoid

1. Don't assume all medications affecting adrenergic systems have the same sleep effects: Propranolol (beta-blocker) disrupts sleep, while mirtazapine (alpha-2 antagonist) promotes it—the receptor subtypes and additional pharmacology matter enormously

2. Don't prescribe propranolol at bedtime for anxious patients expecting it to help sleep: It will likely worsen insomnia 5

3. Don't avoid higher doses of mirtazapine fearing activation: Evidence doesn't support increased insomnia risk at therapeutic doses 10

4. Don't use mirtazapine low-dose monotherapy for major depression: While 15 mg may help sleep, it's inadequate for treating depression 9